Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 17.0B | 16.3B | 10.6B | 15.4B |
Cost of revenue | — | — | — | — |
Gross profit | 17.0B | 16.3B | 10.6B | 15.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 9.7B | 9.5B | 5.2B | 6.9B |
Other operating expenses | 38.5M | 31.4M | 43.2M | 105.1M |
Operating income | 851.8M | 1.5B | -342.8M | 2.7B |
Non operating interest income | ||||
Income | 267.8M | 302.3M | 254.5M | 164.8M |
Expense | 299.1M | 133.1M | 148.0M | 106.1M |
Other income expense | — | — | — | — |
Pretax income | 910.9M | -1.7B | -167.8M | 2.2B |
Tax provision | 1.1B | -314.6M | 87.4M | 509.8M |
Net income | -167.0M | -1.4B | -255.2M | 1.7B |
Basic EPS | — | -141 | -26 | — |
Diluted EPS | — | -141 | -26 | — |
Basic average shares | — | 10.0M | 9.8M | — |
Diluted average shares | — | 10.0M | 9.8M | — |
EBITDA | 1.8B | -1.1B | 502.4M | 3.4B |
Net income from continuing op. | -167.0M | — | -255.2M | 1.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |